Pradaxa Settlement In Lieu of Trial Leaves Xarelto Lawsuit Plaintiffs Hopeful For Similar Results In MDL

June 07, 2016 – – TheProductLawyers.com reports on the status of the current Multidistrict Litigation (MDL 2592) that consolidated the more than 2,800 Xarelto lawsuits filed against the subsidiary company of the Johnson and Johnson Corporation, Janssen Pharmaceuticals, and Bayer AG. The MDL is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of Louisiana.

The plaintiffs involved in all the cases in the MDL are making similar allegations against the drug’s manufacturers that the blood thinner Xarelto can induce very sudden and spontaneous internal and external uncontrollable bleeding that has resulted in many fatalities. Judge Fallon has set a target date of spring 2017 to commence the first 4 bellwether trials against the defendants to be selected out of a pool of 40 cases. As the MDL inches toward the beginning of the litigation process, 400 more cases have been added to it just in the month of August 2015 alone.

The cases that are the focus of the MDL are not the only ones that are progressing forward as a group litigation. The Court of Common Pleas in Philadelphia, PA has created a mass tort program comprised of 550 cases with all of them naming Janssen and Bayer as defendants, claiming similar allegations related to uncontrollable bleeding.

Xarelto plaintiffs are somewhat encouraged in their efforts based on actions taken with Pradaxa, also a new-generation blood thinner drug that experienced the same kind of public scrutiny that Xarelto is now getting. Pradaxa was released on the market by Boehringer Ingelheim in 2010, and it quickly became the focus of more than 4,000 lawsuits because of thousands of adverse event reports that were filed, 750 of which were reporting fatalities. Xarelto plaintiffs are hopeful that what happened with Pradaxa will happen in their situation as on the eve of the start of the trial against Pradaxa’s manufacturer, it announced a $650 million settlement in lieu of going to trial.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010481